LON:ORPH

Open Orphan Share Forecast, Price & News

GBX 35.50

+0.55 (+1.57 %)

(As of 05/14/2021 04:35 PM ET)

Add

Compare

Today's Range

▼

36.45

50-Day Range

▼

52-Week Range

▼

Volume2.46 million shs

Average Volume3.22 million shs

Market Capitalization£237.64 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive ORPH News and Ratings via Email

Sign-up to receive the latest news and ratings for Open Orphan and its competitors with MarketBeat's FREE daily newsletter.

About Open Orphan

Open Orphan plc operates as a clinical research organization pharmaceutical services company with a focus on virology, vaccine studies, and orphan drugs in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. It operates a virtual rep, a pharmaceutical commercialization platform for rare/orphan disease space; and develops Genomic Health Data platform, a collection of infectious disease progression data. The company also provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. In addition, it offers hVIVO COVID Clear Test, an antibody test for employers in the United Kingdom and Ireland. The company is headquartered in London, the United Kingdom.

Open Orphan plc Announces £3m COVID-19 Challenge Virus Manufacturing Contract
May 10, 2021 | finance.yahoo.com

Should I buy Open Orphan shares ahead of the planned demerger?
April 20, 2021 | fool.co.uk

The Open Orphan (ORPH) share price is surging. Should I buy now?
April 13, 2021 | fool.co.uk

Open Orphan looks at potential demerger of certain non-core assets
April 13, 2021 | msn.com

Open Orphan launches new data platform to combat infectious diseases
April 9, 2021 | lse.co.uk

Cathal Friel announces Open Orphan to spin out 4 non-core companies
April 7, 2021 | lse.co.uk

Open Orphan subsidiary signs €8.7m human challenge study contract
March 26, 2021 | msn.com

How Much Of Open Orphan plc (LON:ORPH) Do Insiders Own?
March 26, 2021 | finance.yahoo.com

Anya Taylor-Joy Accepts Golden Globe for The Queen's Gambit with Chess-Inspired Manicure
March 1, 2021 | ca.finance.yahoo.com

Hindi Poetry: Out of paperback and into melodious audio CDs
February 27, 2021 | msn.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange LON

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolLON:ORPH

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.openorphan.com

Phone353 1 644 0007

Employees132

Year FoundedN/A

Sales & Book Value

Annual Sales£10.57 million

Price / Sales22.48

Cash FlowGBX 3.17 per share

Price / Cash Flow11.21

Book ValueGBX 6 per share

Price / Book5.92

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Debt

Debt-to-Equity Ratio20.36

Current Ratio2.72

Quick Ratio2.57

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Miscellaneous

Outstanding Shares669,402,000

Market Cap£237.64 million

Next Earnings Date6/21/2021 (Estimated)

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Open Orphan.

0.0 Community Rank

Outperform Votes
Open Orphan has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Open Orphan has received 5 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Open Orphan has received 100.00% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Open Orphan and other stocks. Vote “Outperform” if you believe ORPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ORPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Open Orphan does not currently pay a dividend.
Dividend Growth
Open Orphan does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Open Orphan insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Open Orphan is -11.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Open Orphan is -11.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Open Orphan has a P/B Ratio of 5.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Open Orphan (LON:ORPH) Frequently Asked Questions

What stocks does MarketBeat like better than Open Orphan?

Wall Street analysts have given Open Orphan a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Open Orphan wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Open Orphan's next earnings date?

Open Orphan is scheduled to release its next quarterly earnings announcement on Monday, June 21st 2021.
View our earnings forecast for Open Orphan.

Who are Open Orphan's key executives?

Open Orphan's management team includes the following people:

Mr. Cathal Martin Friel, Exec. Chairman (Age 56)
Dr. Trevor Michael Phillips, Chief Exec. Officer (Age 60)
Mr. Leo Toole, Group CFO & Director (Age 48)
Mr. Timothy Sharpington, Chief Operating Officer (Age 55)
Dr. Maurice N. Treacy, Chief Commercial Officer

Who are some of Open Orphan's key competitors?

Some companies that are related to Open Orphan include Connect Biopharma (CNTB), Silverback Therapeutics (SBTX), Oxford Biomedica (OXB), Stem (STEM), iTeos Therapeutics (ITOS), Pharming Group (PHAR), Gracell Biotechnologies (GRCL), Vor Biopharma (VOR), Pharvaris B.V. (PHVS), 4D Molecular Therapeutics (FDMT), Bolt Biotherapeutics (BOLT), 22nd Century Group (XXII), Ergomed (ERGO), Biotest Aktiengesellschaft (BIO) and Finch Therapeutics Group (FNCH).
View all of ORPH's competitors.

What is Open Orphan's stock symbol?

Open Orphan trades on the London Stock Exchange (LON) under the ticker symbol "ORPH."

How do I buy shares of Open Orphan?

Shares of ORPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Open Orphan's stock price today?

One share of ORPH stock can currently be purchased for approximately GBX 35.50.

How much money does Open Orphan make?

Open Orphan has a market capitalization of £237.64 million and generates £10.57 million in revenue each year.

How many employees does Open Orphan have?

Open Orphan employs 132 workers across the globe.

What is Open Orphan's official website?

The official website for Open Orphan is www.openorphan.com.

How can I contact Open Orphan?

The company can be reached via phone at 353 1 644 0007.

This page was last updated on 5/14/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Open Orphan Share Forecast, Price & News

Adding

Adding

Adding Open Orphan plc

About Open Orphan

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Book Value per Share Ratio